| Duration of treatment |  |  | Duration of treatment |  |  | ||
---|---|---|---|---|---|---|---|---|
 | <1 month | ≥1 month | OR | 95% CI | <3 month | ≥3 month | OR | 95% CI |
 | N = 41 | N = 38 |  |  | N = 61 | N = 18 |  |  |
Gender n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
Female | 33 (80.5%) | 31 (81.6%) | Ref | Â | 48 (78.7%) | 16 (88.9%) | Ref | Â |
Male | 8 (19.5%) | 7 (18.4%) | 1.07 | 0.35–3.31 | 13 (21.3%) | 2 (11.1%) | 2.17 | 0.44– 10.65 |
Age bands n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
Children (under 17Â years) | 9 (22.0%) | 15 (39.5%) | Ref | Â | 15 (24.6%) | 9 (50.0%) | Ref | Â |
Young people (17-18 years) | 32 (78.0%) | 23 (60.5%) | 2.32 | 0.87–6.21 | 46 (75.4%) | 9 (50.0%) | 3.07 | 1.03– 9.14 |
Deprivation SIMD 2006 n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
1-2 | 1 (2.4%) | 7 (18.4%) | 0.09 | 0.01–0.84 | 5 (8.2%) | 3 (16.7%) | 0.23 | 0.03-1.41 |
3-4 | 3 (7.3%) | 4 (10.5%) | 0.47 | 0.09–2.55 | 6 (9.8%) | 1 (0.6%) | 0.78 | 0.07– 8.93 |
5-6 | 12 (29.3%) | 8 (21.1%) | 0.94 | 0.28–3.09 | 15 (24.6%) | 5 (27.8%) | 0.39 | 0.08– 1.89 |
7-8 | 9 (22.0%) | 9 (23.7%) | 0.63 | 0.19–2.11 | 12 (19.7%) | 6 (33.3%) | 0.26 | 0.06– 1.23 |
9-10 | 16 (39.0%) | 10 (26.3%) | Ref | Â | 23 (37.7%) | 3 (16.7%) | Ref | Â |
Antidepressants n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
Yes | 37 (90.2%) | 28 (73.7%) | Ref | Â | 51 (83.6%) | 14 (77.8%) | Ref | Â |
No | 4 (9.8%) | 10 (26.3%) | 0.30 | 0.09–1.07 | 10 (16.4%) | 4 (22.2%) | 0.69 | 0.19– 2.52 |
Co-prescriptions issued n (%) | Â | Â | Â | Â | Â | Â | Â | Â |
Yes | 20 (48.8%) | 4 (10.5%) | Ref | Â | 22 (36.1%) | 2 (11.1%) | Ref | Â |
No | 21 (51.2%) | 34 (89.5%) | 0.12 | 0.03–0.41 | 39 (63.9%) | 16 (88.9%) | 0.22 | 0.05– 1.06 |